Your browser doesn't support javascript.
loading
The Role of Proline-Proline-Glutamic Acid (PPE) Proteins in Mycobacterium tuberculosis Virulence: Mechanistic Insights and Therapeutic Implications.
Ilesanmi, Ajibola; Odeniran, Oluwasanmi M; Tatsipie, Lenora; Osam Duodu, Emmanuel; Ankrah, Paa Kwesi.
Afiliação
  • Ilesanmi A; Center for Human Systems Immunology, Duke University, Durham, USA.
  • Odeniran OM; Food Science Institute, Kansas State University, Manhattan, USA.
  • Tatsipie L; Drug Development, Pharmaceutical Product Development, Wilmington, USA.
  • Osam Duodu E; Higher Education, University of Maine, Orono, USA.
  • Ankrah PK; Division of Infectious Diseases, Duke University, Durham, USA.
Cureus ; 16(1): e51955, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38333477
ABSTRACT
For decades, tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), has remained a global health challenge. Central to this issue are the proline-proline-glutamic acid (PPE) proteins, which play a pivotal role in the pathogenesis and persistence of MTB. This article explores the molecular mechanisms of PPE proteins and their roles in facilitating MTB's evasion of the host's immune system while enhancing virulence and transmission. Focusing on the structural and functional aspects of PPE proteins, this review provides a detailed analysis of antigenic variation, a crucial mechanism allowing MTB to elude immune detection. It also probes the genetic diversity of these PPE proteins and their complex interactions with host immunity, offering insights into the challenges they pose for therapeutic development. This review delves into the potential of targeting PPE proteins in novel therapeutic strategies, discussing the prospects of drug and vaccine development. The evidence reviewed in this article underscores the pressing need for innovative approaches to combat TB, especially in the face of increasing drug resistance. Ultimately, this review article highlights the untapped potential of PPE proteins in revolutionizing TB treatment, paving the way for breakthroughs in drug and vaccine development.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article